NasdaqCM - Delayed Quote USD

Nuwellis, Inc. (NUWE)

0.9000
-0.0559
(-5.85%)
At close: May 21 at 4:00:00 PM EDT
0.9500
+0.05
+(5.56%)
Pre-Market: 4:55:33 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
8,787
8,740
8,864
8,543
7,921
Cost of Revenue
3,235
3,064
3,881
3,788
3,430
Gross Profit
5,552
5,676
4,983
4,755
4,491
Operating Expense
14,851
16,664
22,613
21,926
24,017
Operating Income
-9,299
-10,988
-17,630
-17,171
-19,526
Net Non Operating Interest Income Expense
--
-5,607
-3,483
-9,247
0
Other Income Expense
5,061
5,435
912
11,902
-19
Pretax Income
-9,845
-11,160
-20,201
-14,516
-19,545
Tax Provision
4
5
8
9
9
Net Income Common Stockholders
-9,848
-10,624
-22,627
-14,525
-19,629
Diluted NI Available to Com Stockholders
-9,848
-10,624
-22,627
-14,525
-19,629
Basic EPS
15.01
-8.41
-403.20
-2.92k
-10.04k
Diluted EPS
15.01
-8.41
-403.20
-2.92k
-10.04k
Basic Average Shares
2,375.8420
1,327.2520
56.1250
4.9710
1.9570
Diluted Average Shares
2,375.8420
1,327.2520
56.1250
4.9710
1.9570
Total Operating Income as Reported
-9,299
-10,988
-17,630
-17,171
-19,526
Total Expenses
18,086
19,728
26,494
25,714
27,447
Net Income from Continuing & Discontinued Operation
-9,849
-11,165
-20,209
-14,525
-19,554
Normalized Income
-13,825.0700
-15,521.8500
-20,807.8200
-23,868.3300
-19,554
Interest Expense
--
5,607
3,483
9,247
0
Net Interest Income
--
-5,607
-3,483
-9,247
0
EBIT
-3,864
-5,553
-16,718
-5,269
-19,545
EBITDA
-3,557
-5,243
-16,356
-4,897
-19,057
Reconciled Cost of Revenue
3,235
3,064
3,881
3,788
3,430
Reconciled Depreciation
307
310
362
372
488
Net Income from Continuing Operation Net Minority Interest
-9,849
-11,165
-20,209
-14,525
-19,554
Total Unusual Items Excluding Goodwill
5,033
5,515
758
11,827
--
Total Unusual Items
5,033
5,515
758
11,827
--
Normalized EBITDA
-8,590
-10,758
-17,114
-16,724
-19,057
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0003
Tax Effect of Unusual Items
1,056.9300
1,158.1500
159.1800
2,483.6700
0
12/31/2021 - 2/16/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ADGM Adagio Medical Holdings, Inc.
1.1500
-2.54%
 
BBLG Bone Biologics Corporation
0.9115
+3.58%
 
IVF INVO Fertility, Inc.
1.9550
-10.32%
 
MOVE Movano Inc.
0.6004
-18.91%
 
NAOV NanoVibronix, Inc.
1.1800
-8.53%
 
HSCS HeartSciences Inc.
3.9000
-13.14%
 
AFIB Acutus Medical, Inc.
0.0110
+10.00%
 
CODX Co-Diagnostics, Inc.
0.2550
-7.27%
 
WOK WORK Medical Technology Group LTD
0.6960
+36.47%
 
DHAI DIH Holding US, Inc.
0.2190
-6.41%